相关实验视频
Updated: Jun 11, 2025
07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
12.3K
黑色素瘤细胞治疗的最新进展
George Nassief1, Angela Anaeme1, Karen Moussa2
1Division of Medical Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA.
International journal of molecular sciences
|September 28, 2024
概括
基于细胞的疗法,包括lifileucel (瘤透性淋巴细胞疗法),为免疫检查点抑制剂耐药的晚期黑色素瘤患者提供了新的希望. 最近的试验显示了有希望的疗效和安全性,扩大了治疗选择.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 免疫检查点抑制剂 (ICI) 改善了恶性黑色素瘤的结果,但许多患者会产生耐药性或副作用.
- 在晚期黑色素瘤中,对于新型治疗方法存在重大未满足的需求.
- 修改患者自身细胞的基于细胞的疗法正在成为一个有前途的治疗途径.
研究的目的:
- 提供针对晚期黑色素瘤的基于细胞的治疗方法的全面审查.
- 分析最近的临床试验数据,这些疗法的疗效和安全性.
- 讨论基于细胞的黑色素瘤治疗目前的局限性和未来的方向.
主要方法:
- 综述多中心II/III期临床试验,评估黑色素瘤的基于细胞的疗法.
- 从C-144-01研究中对lifileucel (瘤透性淋巴细胞疗法) 的数据进行分析.
- 综合有关疗效,安全性,局限性和未来前景的信息.
主要成果:
- 瘤透淋巴细胞 (TIL) 疗法Lifileucel已获得FDA对晚期黑色素瘤的批准.
- 在C-144-01研究中,证明了TIL在对标准疗法的耐药性患者中的疗效和安全性.
- 基于细胞的疗法在解决晚期黑色素瘤治疗缺口方面显示出可行性.
结论:
- 基于细胞的疗法,特别是TILs,在治疗晚期黑色素瘤方面取得了重大进展.
- 最近的临床试验结果和FDA批准证实了这些疗法的潜力.
- 需要进一步的研究来克服局限性并优化基于细胞的治疗方法,以便更广泛地应用.
相关概念视频
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K